Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

69th Pharmacy Practice Seminar • PPS 2021


 
 
The 2021 Pharmacy Practice Seminar is now available on-demand for home-study credit!   The On-Demand 2021 PPS includes recordings of the live webinar that took place September 10-12, plus a variety of other topics that were not included in the live webinar.  All of the TSBP required special topics plus Immunization and Sterile Compounding sessions are all also included in the cost of registration.  View the link below for a complete list of TSBP topics that are included in the program.
 
 
 
 
 
 
THANK YOU to the 350+ participants who joined us for the LIVE webinar on September 10-12!
Those who participated in the live webinar may log in to access any of the on-demand content.
 
 
 
 
On-Demand Access
 
  1. Register for the on-demand program:  If you have not already registered prior to September 12, use the Register Now button down below to register for the On-Demand PPS home study program.  If you registered for PPS prior to September 12, follow the instructions below to log in.
  2. Program Access [Bookmark this page!]    Return to this page whenever you wish to access the home study sessions:  
    • Use the "Login" button at top right page to log in
    • Select "Pending/Private Programs" from the menu bar at the top of the page
    • From the ONLINE CE tab, select "69th Pharmacy Practice Seminar"
    • Then select any of the modules below that you wish to complete and follow the instructions listed in that module.
 
 
 
Registration Fee
 
2021 On-Demand PPS Registration Rate $415
 
Discount Codes:
Pharmacy Technicians (reduces Registration Fee to $150):  21virtualtech
UT Preceptors / Faculty / Residents / Graduate Students ($25 discount off registration fee):  21virtualfaculty
IMPORTANT:  Invalid use of codes will result in canceled registration. Please verify use with UT CPE if you have any questions.
 
 

Fee

$415.00

CE Hours

26.50

CE Units

2.650

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Requirements for CE Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based activity is approved for 26.5 CE hours (home study).  In order to receive 26.50 CE credits, the participant must complete the on demand video activity sessions then complete the online evaluation that follows each accredited session.  After an online evaluation is submitted, CE credit is transmitted directly to CPE Monitor within one week.

It is the participant's responsibility to confirm CE credit has been awarded correctly by logging into their CPE Monitor profile.  Credit discrepancies must be reported to UT Continuing Pharmacy Education within 60 days of submitting an evaluation (CE credit cannot be awarded/corrected after 60 days have passed).  Please ensure that your NABP e-ID and DOB (MM/DD) are entered correctly in your profile prior to completing the evaluations.   

 
 

 

 

   

Objectives

  • View the handout down below for detailed instructions on how to participate in virtual PPS.
Date: 09/10/21
Time: 07:00 PM - 07:00 PM
   

   

 
2021 Immunization Update - 2 CE hours
on-demand home study session
 

About the Faculty

Sharon Rush, RPh
Clinical Associate Professor
The University of Texas College of Pharmacy


Presentations: 2021 Immunization Updates 

Bio:  Sharon Rush received her Bachelor of Science in Pharmacy degree in 1986. She practiced as a staff pharmacist, pharmacy manager, Central Texas Immunization Coordinator, and PGY-1 residency preceptor during her 23 years with a large community pharmacy chain. She joined the faculty of the Division of Pharmacy Practice at The University of Texas at Austin College of Pharmacy in July 2010. She is the Community Introductory Pharmacy Practice Experience Coordinator for the college and the Austin/Temple/Waco Community Advanced Pharmacy Practice Experience Coordinator for the fourth year professional students.
 
Professor Rush has been involved with direct patient care programs for many years, such as pharmacy-based immunizations, health screenings, Medication Therapy Management, and Disease State Management. She is a certified instructor for the APhA Pharmacy-Based Immunization Delivery certificate program for both pharmacists and pharmacy technicians, the APhA Medication Therapy Management certificate program, and the NACDS Point of Care certificate program. All PharmD students at UT earn their immunization and medication therapy management certificates under her instruction.
 
She provides the annual 3-hour continuing education Immunization Update for the Texas Pharmacy Association and The University of Texas College of Pharmacy Pharmacy Practice Seminar. She is a member of several national, state and local professional organizations and serves on the Texas Pharmacy Association’s Public Policy Council and Association Affairs Council. She recently was selected to serve on APhA-APPM’s Immunizing Pharmacists SIG Communications committee and the American Academy of Colleges of Pharmacy Council of Faculties Professional Identity Formation task force.

Disclosure:  Sharon Rush does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Identify changes or updates to the January 2021 Immunization Schedules for persons aged 0 through 18 years and adults.
  • Evaluate the most current Advisory Committee on Immunization Practices (ACIP) recommendations and CDC best practice guidelines.
  • Discuss vaccines under investigation or in the pipeline.

Activity Number

0067-0000-21-138-H06-P/T

Release Date: Sep 10, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

2.00
   

   

 
Heart Failure and High Cholesterol:  Implications of Treatment Guidelines
on-demand home study session
 

About the Faculty
 
James Karboski, PharmD

James A. Karboski, PharmD
Clinical Professor of Pharmacy Practice Neill B. Walsdorf Fellow in Pharmacy
The University of Texas at Austin College of Pharmacy

 
Presentation:  Heart Failure and High Cholesterol:  Practical Implications of Treatment Guidelines
Bio: Dr. Karboski earned a Bachelor of Pharmacy degree from Washington State University in 1985. Subsequently, Dr. Karboski earned his Doctor of Pharmacy degree from the University of Texas at Austin and the University of Texas Health Sciences Center at San Antonio in 1987. He continued his training in Texas where he completed a Clinical Sciences Fellowship in Pharmacokinetics at the University of Texas at Austin. Later, while a faculty member at the University of Iowa, Dr. Karboski was a Geriatrics Fellow of the Iowa Geriatrics Education Center. Dr. Karboski directed the Adult Internal Medicine Residency program in collaboration with Brackenridge Hospital for 15 years, supervised 14 residents and created a program that is nationally recognized as a superior training program for future academicians. Dr. Karboski has authored numerous scientific and professional articles in the areas of clinical therapeutics and pharmacokinetics. He has presented over 200 times before various professional, scientific and student groups. Dr. Karboski is recognized for his contributions to teaching excellence and the use of technology in teaching. Dr. Karboski teaches extensively in the undergraduate, Pharm.D., and graduate programs at the University of Texas. He has been nominated for the prestigious Texas Exes Teaching Award for seven of the last eight years and won the award in 2000. He has been nominated for the Regents’ Outstanding Teaching Award for the past two cycles and has been cited by the P4 class as a faculty member who had the highest impact on their professional development for each of the past six years. He has served as the Section Editor – Cardiovascular Diseases for the APhA Drug Treatment Protocols, Section Editor – Cardiovascular Diseases for ASHP’s PharmPrep 3rd Edition, Chair of the Biomedical Research Group Investigational Review Board and item writer and board member for the NABP Foreign Pharmacy Equivalency Exam.
Disclosure: James A. Karboski does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Discuss Opening Remarks PPS 2021 - Jennifer Bosworth, PharmD, Assistant Director, UT CPE
  • Discuss the impact of guidelines / evidence-based data on the treatment of heart failure.
  • Discuss the impact of guidelines / evidence-based data on the treatment of high cholesterol.
  • Identify treatment options for heart failure and/or high cholesterol based on patient-specific information and treatment guidelines.

Activity Number

0067-0000-21-139-H01-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
503B Outsourcing Facilities:  What is the Impact on Pharmacy Practice
on-demand home study session
 

About the Faculty
 

Greg Rockers, R.Ph.
Managing Director
The Williamson Rockers Group,LLC

Bio: Greg is Managing Director for The Williamson Rockers Group (WRG). WRG is a consulting firm that helps peers and colleagues in the sterile compounding industry achieve and maintain regulatory compliance. WRG brings an owner's mentality to its consulting engagements. WRG “thinks like owners,” because its consultants have walked in your shoes. Greg has over 27 years of experience in pharmacy management, 17 years of experience in 503A/503B sterile compounding and 18 years of experience in pharmaceutical research. He has operated two 503B Outsourcing Facilities, has assisted organizations in navigating multiple FDA inspections and now conducts audits for 503A and 503B facilities. Greg has real-world, hands-on experience in all facets of running an FDA compliant compounding facility including aseptic processing, formulation development, cGMP gap analysis and remediating 483 observations. Additional areas of emphasis include helping clients buy, sell and raise capital as well as insurance policy exposure audits.
 
Disclosure: Greg Rockers is Managing Director of The Williamson Rockers Group, a consulting firm that helps peers and colleagues navigate the sterile compounding industry.  This financial relationship was mitigated with a peer-review of content prior to the activity by a knowledgeable practitioner who has no relevant financial relationships. The review ensured the content is valid and free from commercial influence.


 

Brian Williamson, PharmD
Managing Director
The Williamson Rockers Group, LLC

Bio: Brian is Managing Director for The Williamson Rockers Group (WRG). WRG is a consulting firm that helps peers and colleagues in the sterile compounding industry achieve and maintain regulatory compliance. WRG brings an owner's mentality to its consulting engagements. WRG “thinks like owners,” because its consultants have walked in your shoes.  Brian uses his expertise in the sterile pharmaceutical compounding industry to help business owners and senior leaders maximize the value in their businesses. As a former founder, owner and operator of a nationally recognized sterile compounding pharmacy and FDA-registered 503B Human Drug Outsourcing Facility, Williamson gained the real-world, hands-on experience that is vitally important to assist other firms in executing financial and quality strategies for success. Brian successfully sold his sterile pharmaceutical compounding firm, JCB Laboratories, in 2014. One of the biggest mistakes he admits he made was not retaining the help of professional investment bankers to help with the process. He now advises business owners that using “do-it-yourself” financial and regulatory readiness is often the best way to leave significant money on the table when closing day comes.
 
Disclosure: Brian Williamson is Managing Director of The Williamson Rockers Group, a consulting firm that helps peers and colleagues navigate the sterile compounding industry.  The financial relationship was mitigated with a peer-review of content prior to the activity by a knowledgeable practitioner who has no relevant financial relationships. The review ensured the content is valid and free from commercial influence.

 

Objectives

  • Define 503B compounding pharmacies.
  • Discuss challenges surrounding 503B dispensing.
  • Examine the impact that 503B outsourcing facilities have on community pharmacy

Activity Number

0067-0000-21-140-H04-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
Pain Management and Complex Persistent Opioid Dependence (CPOD)
on-demand home study session
 
NOTE:  This module may be counted as one hour of CE related to Pain Management as outlined by TSBP rule 295.8(d)(1)(B)
 

About the Faculty
 

Ajay Manhapra, MD
Section Chief, Pain Medicine
Hampton VA Medical Center
Lecturer, Department of Psychiatry Yale School of Medicine


Presentation:   Re-Evaluation of Long-Term Opioid Therapy (LTOT) Among Patients with Complex Persistent Opioid Dependence (CPOD)
Bio: Dr. Manhapra is a Lead Physician at the Advanced PACT Pain Clinic in Hampton VA Medical Center, Hampton, Virginia.  He is a Research Scientist, VA New England Mental Illness Research, Education and Clinical Center, West Haven, CT.  In addition, Dr. Manhapra is a Lecturer for the Department of Psychiatry at Yale School of Medicine in New Haven, CT.
Disclosure: Ajay Manhapra does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Objectives

  • Differentiate Complex Persistent Opioid Dependence (CPOD) from Opioid Use Disorder (OUD).
  • Describe identification, management, and mitigation of CPOD in patients taking Long-Term Opioid Therapy (LTOT).
  • Develop patient-centered plans for risk mitigation among LTOT patients.

Activity Number

0067-0000-21-141-H08-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
What Every Pharmacist Needs to Know About Buprenorphine for OUD
on-demand home study session
 
NOTE:  This module may be counted as one hour of CE related to Prescribing and Monitoring Controlled Substances as outlined by TSBP rule 295.8(d)(1)(C)
 

About the Faculty
 
Lucas G. Hill, PharmD
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
 
Bio: Lucas G. Hill graduated from the UMKC School of Pharmacy and completed a combined residency/fellowship in the UPMC Department of Family Medicine. He is now a clinical assistant professor of pharmacy practice at The University of Texas at Austin College of Pharmacy. Dr. Hill is Director and Principal Investigator of Operation Naloxone, an interprofessional opioid overdose prevention program funded through the Texas Targeted Opioid Response. His research is focused on clinician-community collaborations to address substance use disorders through evidence-based treatment and harm reduction strategies. Dr. Hill coordinates the first year of the UT Foundations for Interprofessional Collaborative Practice curriculum and leads the embedded addiction module. He provides an additional 16 hours of addiction-related instruction in the required pharmacy curriculum and precepts both the overdose prevention service IPPE and addiction medicine elective APPE. He also serves as faculty advisor for the UT Student Pharmacist Recovery Network. In 2018, Dr. Hill was awarded the GenerationRx Champion Award for excellence in addiction-related education by the Texas Pharmacy Association and Cardinal Health.
 
Disclosure: Lucas Hill receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services


 
 

Lindsey J. Loera, Pharm.D.
PhARM Fellow
The University of Texas at Austin College of Pharmacy
Clinical Pharmacist, CARMAhealth Management, Inc

Bio: Dr. Loera graduated from The University of Texas at Austin College of Pharmacy in May 2020 and is currently completing a two-year fellowship with the Pharmacy Addictions Research & Medicine (PhARM) Program. In this role, she is developing an innovative clinical pharmacy practice at an outpatient medical home for substance use disorders and conducts statewide research exploring the pharmacist’s role in addiction treatment. She previously served as President of the Student Pharmacist Recovery Network and co-founded the Addiction Medicine Advanced Pharmacy Practice Experience.
 
Disclosure: Lindsey J. Loera does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Recall mechanism, formulations, dosing, and regulations related to buprenorphine.
  • Describe evidence supporting safety and efficacy of buprenorphine.
  • Discuss current ethical and legal controversies related to buprenorphine

Activity Number

0067-0000-21-142-H05-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
Texas Pharmacy Law Update
on-demand home study session
 

About the Faculty

Allison Vordenbaumen Benz, RPh, MS Former Executive Director / Secretary Texas State Board of Pharmacy


Presentation:  Texas Pharmacy Law Update
Bio: Allison Vordenbaumen Benz graduated from the University of Texas, College of Pharmacy in August 1988 and completed a Master’s of Science degree in Pharmacy Administration through the Option II program at the University of Texas at Austin in December 1994. Following graduation, she worked as a community pharmacist in California and Texas. Allison has been an employee of the Texas State Board of Pharmacy since August 1994 and has served for 6-years as Senior Enforcement Officer, 3-years as Assistant Director of Enforcement, and 14-years as Director of Professional Services before being appointed to her present position on December 1, 2017. In her position as Executive Director, Allison serves as the chief executive officer of the agency and an ex-officio member and secretary of the Board. Allison is a member of the Capital Area Pharmacy Association; the National Association of State Controlled Substances Authorities; the National Alliance for Model State Drug Laws, Prescription Monitoring Program Resource Group; and the National Charity League, Inc., Capital of Texas Chapter. Her awards include the Texas Pharmacy Association, “Forty Under 40” Award in July 2006.
Disclosure: Allison Benz does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Cite recent changes in pharmacy laws and rules and their impact on daily practice.
  • Discuss applicability of Texas Pharmacy Laws to preceptor development.
  • Discuss specific practice scenarios/questions regarding Texas pharmacy laws and rules.

Activity Number

0067-0000-21-143-H03-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
Treatment Advances in Multiple Sclerosis
on-demand home study session
 

About the Faculty
 

Jacquelyn L. Bainbridge, BSPharm , PharmD, FCCP, MSCS, FAES Professor, Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences Professor, Department of Neurology Anschutz Medical Campus University of Colorado


Presentation:  Treatment Advances in Multiple Sclerosis
Bio: Jacquelyn L. Bainbridge, BSPharm, PharmD, FCCP, MSCS, FAES, is a Professor at the University of Colorado Anschutz Medical Campus, where she holds joint appointments in the Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, and the Department of Neurology in the School of Medicine. Dr Bainbridge received her doctorate in pharmacy from the University of Colorado in Denver, where she subsequently completed a specialty residency in neurology. Dr Bainbridge is a Multiple Sclerosis Certified Specialist (MSCS) who is actively involved in clinical research in many areas of neurology, including epilepsy, multiple sclerosis (MS), Parkinson’s disease (PD), back pain and cannabis.  She has reviewed and written several book chapters on MS, epilepsy, migraine, chronic pain, women’s issues, pharmacokinetics, and the practice of pharmacy. Dr Bainbridge is a frequent lecturer on topics of neurologic and pharmacologic interest, including chronic pain disorders, epilepsy, migraines, movement disorders, MS, neuroprotection, restless legs syndrome, Huntington’s disease and the administration of cannabis for therapeutic intent.
Disclosure: Jacquelyn L. Bainbridge does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Briefly describe the pathophysiology of multiple sclerosis (MS) and its symptomatic impact on patients’ quality of life.
  • Explain the available pharmacologic treatment approaches for multiple sclerosis with regards to disease subtype, mechanism of action, effectiveness and adverse effects.
  • Identify emerging treatments and the potential impact on practice.
  • Explain how pharmacists can assist patients to address key barriers MS patients often face when managing their illness.

Activity Number

0067-0000-21-145-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
Shining a Light on Migraines:  A Closer Look at Treatment and Prevention
on-demand home study session
 

About the Faculty

Kristin M. Janzen, PharmD, BCPS
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy


Presentation: Shining a Light on Migraines: A Closer Look at Treatment and Prevention
Bio: Kristin Janzen is a Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy. After graduating from UT College of Pharmacy, she completed a combined PGY1 & 2 Pharmacotherapy residency at Butler University and Indiana UniversityHealth in Indianapolis, IN, where she stayed on faculty for a year prior to returning home to UT. She currently practices at Dell Seton Medical Center at the University of Texas in Internal Medicine, where she precepts APPE students and residents on academic internal medicine rotations. Her research and teaching interests focus on core medicine disease states, such as pulmonology, cardiology, diabetes, and interprofessional education.
Disclosure: Kristin Janzen has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.

 

Objectives

  • Differentiate symptoms of headache, migraines and potentially life-threatening conditions for the purpose of referring patients to appropriate treatment or medical attention.
  • Describe new and existing prescription medications used for the prevention of migraine headaches.
  • Describe new and existing prescription medications used for the treatment of migraine headaches.
  • Examine the impact and treatment of migraines in children/adolescents.

Activity Number

0067-0000-21-146-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
Immunizations and COVID-19:  Where Are We Now?
on-demand home study session
 

About the Faculty

Sharon Rush, RPh
Clinical Associate Professor
The University of Texas College of Pharmacy


Presentations: Immunizations and COVID-19 - Where Are We Now and Where Are We Headed? 

Bio:  Sharon Rush received her Bachelor of Science in Pharmacy degree in 1986.  Sharon Rush practiced as a staff pharmacist, pharmacy manager, Central Texas Immunization Coordinator and PGY1 residency preceptor during her 23 years with a large community pharmacy chain.  She has been involved with different patient care programs such as pharmacy-based immunizations, health screenings, Medication Therapy Management and Disease State Management. is a certified instructor for the APhA “Pharmacy-Based Immunization Delivery” certficate program, the APhA “Delivering Medication Therapy Management Services in the Community” certificate program and is an American Heart Association Basic Life Support instructor.  She was honored with the “Friend of UT-APhA-ASP” award in 2010 and 2011 for her involvement with their health screening events.
Disclosure:  Sharon Rush does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Objectives

  • Discuss the status of COVID-19 with regards to immunizations and variants in U.S.
  • Examine the impact of COVID-19 pandemic on the status of non-covid vaccinations/preventable diseases.
  • Discuss vaccine hesitancy and special populations who may not wish to receive the COVID-19 vaccine and the impact/forecast on reaching herd immunity in the U.S.

Activity Number

0067-0000-21-147-H06-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
The Impact of COVID-19 on Mental Health in Older Adults
on-demand home study session
 
This module may be counted as one hour of CE related to Mental Health Awareness, as outlined by TSBP rule 295.8(d)(1)(D).
 

About the Faculty
 
Cherie Simpson, PhD, APRN-CNS
Senior Adults Specialty Healthcare

Presentation:  The Impact of COVID-19 on Mental Health in Older Adults

Bio: Cherie Simpson, PhD, APRN-CNS is currently a Clinical Nurse Specialist with Senior Adult Specialty Healthcare, where she provides medical management to geriatric psychiatric patients, predominantly with a diagnosis of dementia.  Cherie earned her MBA from St. Edward's University and continued on to earn a masters in Adult Health Nursing and her Doctorate in nursing at The University of Texas at Austin School of Nursing.  Cherie has years of experience conducting and disseminating scholarly research, while completing her graduate studies at The University of Texas School of Nursing and throughout her practice career. Cherie's extensive research experience in the field of psychiatry is demonstrated by her countless publications and presentations at a local, regional and national level.  Cherie has also received multiple honors and awards over the years for her studies, research and publications in psychiatric practice and continues to actively serve on a wide variety of professional service organizations.


Disclosure: Cherie Simpson does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

 

Objectives

  • Explain how the COVID-19 pandemic has affected the mental health of older adults.
  • Describe strategies (healthy and unhealthy) that many seniors have employed to cope during the pandemic.
  • Identify how healthcare providers can support seniors during the pandemic.

Activity Number

0067-0000-21-148-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.00
   

   

 
 
Pancreatic Cancer Update
on-demand home study session
 

Scott Soefje, PharmD, MBA, BCOP, FCCP 

Director, Pharmacy Cancer Care
Mayo Clinic Assistant Professor of Pharmacy
Mayo Clinic College of Medicine and Science

 
Presentation:  Pancreatic Cancer Update
Bio: Scott earned his BS Pharmacy from UT Austin and then after five years of hospital practice, he returned to earn a PharmD from UT Austin. He completed a Specialty Residency in Oncology Pharmacy at the San Antonio VA and a Clinical Pharmacology Fellowship at the M.D. Anderson Cancer Center. He obtained an MBA from George Washington University. He has been Board Certified in Oncology Pharmacy since 2000.
Disclosure: Scott Soefje has disclosed the following relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence):  Note:  UT CPE mitigated the following financial relationships by having Dr. Soefje's content peer-reviewed prior to the activity by a knowledgeable practitioner who has no relevant financial relationships.  The review ensured the content is valid and free from commercial influence. Pfizer - Speaker's Bureau Merck - Consulting Beigene - Consulting

 

Objectives

  • Examine briefly treatment approaches for pancreatic cancer.
  • Discuss challenges to treating this cancer.
  • Discuss opportunities for pharmacists to support patients with pancreatic cancer.

Speaker(s)/Author(s)

Scott Soefje, Pharm.D., MBA, BCOP, FCCP picture

Scott Soefje, Pharm.D., MBA, BCOP, FCCP
Director of Pharmacy, University Medical Center Brackenridge

Activity Number

0067-0000-21-149-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.00
   

   

 
 
mRNA vs. DNA Therapies - Current and Future Applications
on-demand home study session
 

Zhengrong Cui, Ph.D. Professor of Molecular Pharmaceutics and Drug Delivery Alfred and Dorothy Mannino Fellow in Pharmacy

 
Presentation:  mRNA and DNA Therapies - Current and Future Applications
Bio: Zhengrong Cui is a Professor at The University of Texas at Austin (UT Austin), College of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery. His research interests lie in pharmaceutical drug and vaccine delivery. He also has extensive experience in freeze drying of biologics and their needle-free delivery. Dr. Cui published extensively in the fields of pharmaceutics, vaccinology, and nanotechnology, including numerous peer-reviewed research papers, review papers, and book chapters. He is a co-inventor on many patents and patent applications. He serves as an editor to International Journal of Pharmaceutics, and as a reviewer for numerous scientific journals as well as national and international funding agencies. Dr. Cui teaches Biopharmaceutics to professional Doctor of Pharmacy students and Advanced Biopharmaceutics to graduate students and is a UT Austin Provost’s Teaching Fellow. Dr. Cui holds a Ph.D. degree in Pharmaceutical Sciences from the University of Kentucky, College of Pharmacy and completed his postdoctoral training at the University of Pittsburgh, School of Pharmacy. He is a Fellow of the American Association for Pharmaceutical Scientists.
Disclosure: Zhengrong Cui does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Describe the mechanism of action of mRNA therapies and how they differ from DNA therapies.
  • Examine the current and future applications of these therapies in healthcare.
  • Discuss potential ethical considerations with mRNA or DNA therapies.

Activity Number

0067-0000-21-150-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.00
   

   

 
2021 New Drug Update
on-demand home study session
 
Dr. Ryan and Dr. Pedigo both reported they do not have any financial relationships to disclose.

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses and dosing of selected prescription drugs recently marketed.
  • Examine the role of currently marketed and emerging therapeutics in the prevention/management of COVID-19.

Speaker(s)/Author(s)

Justin Pedigo picture

Justin Pedigo, PharmD, BCPP
Clinical Assistant Professor, The University of Texas College of Pharmacy

Laurajo Ryan, PharmD, MSc, BCPS, CDE picture

Laurajo Ryan, PharmD, MSc, BCPS, CDE, Pharm.D., MSc, BCPS, CDE
Clinical Associate Professor, UT Austin College of Pharmacy / UTHSCSA

Activity Number

0067-0000-21-114-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.25
   

   

 
 
New Agents for Mental Health and Neurologic Disorders
on-demand home study session
 
This module may be counted as one hour of CE related to Mental Health Awareness, as outlined by TSBP rule 295.8(d)(1)(D).
 
Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy
 

Dr. Saklad was born in Los Angeles, California in 1953, and graduated from Pacific Palisades High School in 1970. He received his baccalaureate degree cum laude in Bacteriology from the University of California, Los Angeles in 1974. His Doctor of Pharmacy degree was earned at the University of Southern California in 1978. He had a National Institute of Mental Health training fellowship in Psychiatric Pharmacy supervised by Jim Wilson, Pharm.D., BCPP at the Nebraska Psychiatric Institute of the University of Nebraska Medical Center at Omaha in 1978-9. He then joined the faculty of The University of Texas at Austin College of Pharmacy and the clinical staff at San Antonio State Hospital (SASH) in 1979. He was the first clinical pharmacist employed by the Texas Department of Mental Health and Mental Retardation (now Texas Health and Human Services) when he began as Clinical Coordinator at SASH. He has lived in San Antonio, Texas since 1979. He is married and the father of triplet sons.

During his 38 years career, Dr. Saklad has provided clinical care, education, and research in a variety of settings and treatment roles at SASH. He team teaches didactic courses for second and third professional year pharmacy students. He is the course director for Advanced Pharmacotherapy Laboratory, a third professional year opportunity for students to develop their clinical presentation skills that is given across four campuses. He precepts and mentors third and fourth professional year pharmacy students (P3’s & P4’s) at SASH. He received the UT Austin College of Pharmacy’s Teaching Award from the Class of 2014. He authored and successfully discussed with members of the Texas Legislature the creation of a clinical research unit at SASH that was funded by the Texas Legislature and jointly governed by the UT Austin College of Pharmacy, UT Health Science Center San Antonio Department of Psychiatry and SASH.

Dr. Saklad initiated and developed the first websites for the UT Austin College of Pharmacy in 1994, the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997, and the CPNP Foundation in 2015. He helped to design, organize and was a founding member of CPNP when it incorporated in 1998 as well as the CPNP Foundation in 2012. In 2003, he was elected to the Board of Directors of the CPNP for a two-year term. He has served as a member or officer of the CPNP Communications Committee since the creation of CPNP from 1995 to 2011 and was the Founding Senior Editor of the Mental Health Clinician, CPNP’s Open Access journal, from 2011-13. Currently, Dr. Saklad is Treasurer of the CPNP Foundation a member of the CPNP Business Development Committee. He was on the task force that developed The Mental Health Pharmacy Directory to improve patient access. He is the Director of The University of Texas Psychiatric Pharmacy Program. In 1988, he helped to create and has chaired The University of Texas at Austin College of Pharmacy’s Psychiatric Pharmacotherapy Update since 2007.

Dr. Saklad publishes articles and presents to many groups around the country on a variety of pharmacy and mental health-related topics. He edited Psychopharmacology Update newsletter from 1998-2002 and edited two editions of a compendium based upon this newsletter, Psychopharmacology Desktop Reference, published by Manisses Communications Group in 1999 and 2002. He provides updates on his Twitter feed on a variety of topics @pharmacopsych.

Dr. Saklad is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, depression, and other serious and persistent mental illness, as well as their pharmacokinetics and interactions. He was the Director of UT Health Science Center San Antonio’s Advanced Pharmacotherapy Research with research facilities located at Laurel Ridge Treatment Center and President of Alamo Superior Research, LLC. He has been affiliated with the Behavioral Wellness (“Be Well”) Center, Department of Psychiatry, UT Health San Antonio since 2009.


Disclosure: Dr. Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

  • Employee of Texas Department of Health Services San Antonio
  • Speakers Bureau: Actavis, Otsuka, Sunovion
  • Consultant: Janssen, Jazz, Otsuka, Teva
  • Other: Member of Pharmacists Foundation, Business Development Council for San Antonio

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.


Objectives

  • Describe the efficacy and safety data of the emerging and recently approved psychiatric and neurologic medication pipeline.
  • Discuss appropriate monitoring requirements, patient education points, and provider education for these agents.
  • Discuss clinical use of new and emerging medications.

Activity Number

0067-0000-21-126-H04-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.00
   

   

This project is funded by Texas Health & Human Services Texas Targeted Opioid Response
 
Management of Acute Pain in Patients with Opioid Use Disorder
on-demand home study session
NOTE:  This module may be counted as one hour of CE related to Pain Management, as outlined by TSBP rule 295.8(d)(1)(B).
 
About the Faculty 
Dr. Kirsten Mason is a graduate of the University of Tennessee Health Science Center College of Pharmacy. She completed her PGY1 Pharmacy Residency at Memphis Veterans Affairs Medical Center and her PGY2 Internal Medicine Residency at University Medical Center Brackenridge in Austin, TX. Immediately after residency training, Dr. Mason accepted a clinical pharmacy specialist position in cardiology at Northwestern Memorial Hospital in Chicago. In 2016, she had an opportunity to relocate back to Austin and she joined Dell Seton Medical Center at University of Texas as an Internal Medicine Clinical Pharmacy Specialist. In this role, she assisted in the development of an inpatient opioid use disorder treatment service. In November of 2018, Dr. Mason transitioned roles within Ascension Texas to a Regional Clinical Pharmacy Manager with an emphasis on project management and pain management. She also serves as a preceptor for University of Texas College of Pharmacy and Texas A&M College of Pharmacy. Dr. Mason continues to advocate for treatment of opioid use disorder across the continuum of care and educate healthcare providers about medications for opioid use disorder. More recently, Dr. Mason is serving as Interim Director of Pharmacy at Ascension Seton Northwest.

Disclosure: Dr. Mason has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

  • Consultant: Macromoltek Grant Consultant

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.


This module may be counted as one hour of CE related to Pain Management, as outlined by TSBP rule 295.8(d)(1)(B)

 

Speaker(s)/Author(s)

Kirsten Mason, PharmD, BCPS, PharmD, PCPS
Clinical Pharmacy Manager, Seton Healthcare Family

Activity Number

0067-0000-21-108-H08-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022

CE Hours

1.00
   

   

 
 
Building Resilience to Protect Against Burnout
on-demand home study session
 
This presentation has been reviewed by the Texas Consortium on Experiential Programs and has been approved as preceptor education and training for Texas Preceptors.
 
Dr. Chasse does not have any relevant financial relationships to disclose.

Speaker(s)/Author(s)

Ashley Chasse, PharmD
Communicty Resident

Activity Number

0067-9999-21-134-H04-P

Release Date: Aug 6, 2021
Credit Expiration Date: May 31, 2022

CE Hours

0.75
   

   

 
 
Providing Practical Feedback to Trainees & Preceptors
on-demand home study session
 
This presentation has been reviewed by the Texas Consortium on Experiential Programs and has been approved as preceptor education and training for Texas Preceptors.
 
Dr. Canada does not have any financial relationships to disclose.

Speaker(s)/Author(s)

Todd Canada, Pharm.D., BCNSP, FASHP, FTSHP
UT MD Anderson

Activity Number

0067-9999-21-133-H04-P

Release Date: Aug 6, 2021
Credit Expiration Date: May 31, 2022

CE Hours

1.50
   

   

 
 
Experiential Learning During COVID-19: The Good, the Bad, and the Ugly - Preceptor Credit
 
This presentation has been reviewed by the Texas Consortium on Experiential Programs and has been approved as preceptor education and training for Texas Preceptors.
 
Learning Objectives 
  • Discuss preceptor pearls learned through the pandemic
  • Review approached specific with IPPE and APPE students
  • Discuss advantages and disadvantages of using virtual technologies in residency recruitment, staff meetings, teaching and precpting, etc

Faculty 
Justin Pedigo, Pharm.D., BCPS
Clinical Assistant Professor  
The University of Texas at Austin College of Pharmacy
 
Justin Pedigo is a clinical assistant professor and Regional Internship Program Director for the San Antonio region at the University of Texas at Austin College of Pharmacy, and he completed his Doctor of Pharmacy training at Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy in Abilene, Texas. Dr. Pedigo completed a two-year Pharmacotherapy Residency in Lubbock, Texas with TTUHSC, and afterwards he served as a drug information clinical practice specialist with the University of Texas Medical Branch Correctional Managed Care in Huntsville, Texas. Dr. Pedigo provides drug information consultant services to the Texas Department of Health and Human Services Vendor Drug Program and University Health Systems. As a drug information pharmacist, Dr. Pedigo has provided evidence-based population health services to the state offender population including writing evidence-based treatment guidelines and algorithms, and he has provided education to a wide array of healthcare professionals.
 
Disclosure:  Dr Pedigo has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.
 

Gerard Gawrys, PharmD, BCPS, BCIDP
Infectious Disease Pharmacy Specialist
Residency Program Director
Methodist Hospital and Methodist Children’s Hospital
 
After graduating from the St. Louis college of Pharmacy, Dr. Gawrys completed a PGY1 pharmacy practice residency at the VA Hudson Valley HealthCare System in Castle Point, New York. Here, Dr. Gawrys was able to gain knowledge in overall clinical and administrative aspects of patient care and the profession of pharmacy. From there, he completed a PGY2 residency in infectious diseases at the Milwaukee VA Medical Center where he was able to focus on his passion for antimicrobial stewardship and infectious disease pharmacotherapy.  Utilizing his experiences in PGY1 and PGY2, Gerard has served as an infectious disease clinical pharmacy specialist since August 2013, coordinating antimicrobial stewardship efforts with a multidisciplinary team at Methodist Healthcare System in San Antonio. His day to day responsibilities include daily antimicrobial stewardship, infectious disease consultations, and precepting pharmacy students from UT Austin and UIW. Gerard serves as the residency program director for the expanding PGY1 pharmacy residency program at Methodist Hospital and Methodist Children’s Hospital. He is a board certified in infectious diseases pharmacist.
 
Disclosure: Dr. Gawrys has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-21-117-H04-P

Release Date: Aug 6, 2021
Credit Expiration Date: May 31, 2022

CE Hours

1.00
   

   

 
Sterile Compounding - Refining Aseptic Technique
on-demand home study session
 

About the Faculty
 
Holli Temple, Pharm.D.
Clinical Associate Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy

Dr. Holli Temple is a Clinical Assistant Professor in the Health Outcomes & Pharmacy Practice Division. She is a Course Coordinator for Introduction to Patient Care and the associated Care and Respect for the Elderly (CARE) Program. Additionally, she is the Inpatient Coordinator for Advanced Health Outcomes & Pharmacy Practice Experiences, Austin/Temple/Waco region.  Previously, Dr. Temple practiced pharmacy at North Austin Medical Center (NAMC) from 1995 – 2011.  Her responsibilities at NAMC focused on implementing and managing Clinical Pharmacy Services. In addition, she facilitated the Medication Safety Group and served as the NAMC representative to the Austin Multi-Institutional Review Board.   From 2000-2011, Dr. Temple precepted students on Adult Medicine and Institutional Pharmacy rotations and served the UT College of Pharmacy as the Institutional Coordinator for the Austin/Temple/Waco region. She has contributed to ASHP’s PharmPrep publication as an author and continues to be a section editor for the Renal Disorders chapter.  Academically, Holli completed her B.S. in Biomedical Science from Texas A&M University in 1992, her B.S. in Pharmacy from the University of Texas in 1994, and her Doctor of Pharmacy from the University of Texas in 1999. Dr. Temple has received the following honors and awards associated with her pharmacy practice: recipient of the 2004 Caregiver of the Year award from North Austin Medical Center, named to the 2003 Rho Chi Alumni Honor Roll, and recipient of the 2002 Wm. Arlyn Kloesel Outstanding Preceptor Award.

Disclosure: Dr. Temple has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.


This module may be counted as .50 of CE for Sterile Compounding certification maintenance

Objectives

  • Discuss selected terminology used in sterile compounding
  • Demonstrate hand positions that minimize risk of shadowing
  • Setup LAFW (hood) to optimize workflow
  • Identify shadowing of critical sites and recommend corrections

Activity Number

0067-0000-21-127-H07-P/T

Release Date: Jun 18, 2021
Credit Expiration Date: Jun 15, 2024

CE Hours

0.50
   

   

 
Sterile Compounding - Is Lumen Volume Really a Thing?
on-demand home study session
 

About the Faculty
 
Holli Temple, Pharm.D.
Clinical Associate Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy

Dr. Holli Temple is a Clinical Assistant Professor in the Health Outcomes & Pharmacy Practice Division. She is a Course Coordinator for Introduction to Patient Care and the associated Care and Respect for the Elderly (CARE) Program. Additionally, she is the Inpatient Coordinator for Advanced Health Outcomes & Pharmacy Practice Experiences, Austin/Temple/Waco region.  Previously, Dr. Temple practiced pharmacy at North Austin Medical Center (NAMC) from 1995 – 2011.  Her responsibilities at NAMC focused on implementing and managing Clinical Pharmacy Services. In addition, she facilitated the Medication Safety Group and served as the NAMC representative to the Austin Multi-Institutional Review Board.   From 2000-2011, Dr. Temple precepted students on Adult Medicine and Institutional Pharmacy rotations and served the UT College of Pharmacy as the Institutional Coordinator for the Austin/Temple/Waco region. She has contributed to ASHP’s PharmPrep publication as an author and continues to be a section editor for the Renal Disorders chapter.  Academically, Holli completed her B.S. in Biomedical Science from Texas A&M University in 1992, her B.S. in Pharmacy from the University of Texas in 1994, and her Doctor of Pharmacy from the University of Texas in 1999. Dr. Temple has received the following honors and awards associated with her pharmacy practice: recipient of the 2004 Caregiver of the Year award from North Austin Medical Center, named to the 2003 Rho Chi Alumni Honor Roll, and recipient of the 2002 Wm. Arlyn Kloesel Outstanding Preceptor Award.

Disclosure: Dr. Temple has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.


This module may be counted as .50 of CE for Sterile Compounding certification maintenance

Objectives

  • Review anatomy of syringes and needles
  • Define and demonstrate lumen volume
  • Apply knowledge of lumen volume to compounding scenarios

Activity Number

0067-0000-21-128-H07-P/T

Release Date: Jun 19, 2021
Credit Expiration Date: Jun 15, 2024

CE Hours

0.50
   

   

 
Sterile Compounding - Training and Competency Assessments
on-demand home study session
 

About the Faculty 
 
Emory S. Martin, Pharm.D.
Pharmacy Project Specialist
Steward Health Care

Emory is a native of Houston, Texas and married Carolyn Reed of Rexburg, Idaho after he completed two years of voluntary missionary service in Japan.  They have five children and 16 grandchildren.  Emory graduated with a PharmD degree from UC San Francisco in 1984.  In his first month of hospital clinical rotations as a pharmacy student, he set a career path toward hospital pharmacy and student precepting.  He completed two years of clinical residency training at University of Michigan Hospitals, Ann Arbor.  In 1986, he joined the clinical pharmacy faculty at The University of Texas College of Pharmacy precepting adult medicine rotations.  In 1990 he transitioned to part-time UT faculty status as he practiced hospital pharmacy in Austin, Round Rock, and Temple serving as a clinical pharmacy coordinator, hospital pharmacy director, and multi-hospital system pharmacy administrator.  He continued to precept hospital pharmacy, adult medicine, infectious disease, and pharmacy administration APPE rotations, as well as IPPE rotations with students through 2017 – for a total of thirty years of student precepting.  For eight years he served as hospital pharmacy residency program director.  Emory has held a visiting professor appointment with Toho University Faculty of Pharmaceutical Sciences, in Chiba, Japan for 12 years.  He served on the Board of Directors of the Texas Society of Health System Pharmacists for 10 years, including serving one term as President.

Disclosure:  Dr Martin has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.


This module may be counted as 1.00 hour of CE for Sterile Compounding certification maintenance

Objectives

  • Characterize a quality onboarding training program.
  • Describe a compliant competency assessment program, including how to identify and remediate “failure”.
  • Technician Objectives
  • Explain the need and methods of site-specific IV training at onboarding
  • List the TSBP-required onboarding competency assessments.

Activity Number

0067-0000-21-129-H07-P/T

Release Date: Jun 18, 2021
Credit Expiration Date: Jun 15, 2024

CE Hours

0.50
   

   

 
Sterile Compounding - Compounding Documentation and Workflow
on-demand home study session
 

About the Faculty
 
Emory S. Martin, Pharm.D.
Pharmacy Project Specialist
Steward Health Care

Emory is a native of Houston, Texas and married Carolyn Reed of Rexburg, Idaho after he completed two years of voluntary missionary service in Japan.  They have five children and 16 grandchildren.  Emory graduated with a PharmD degree from UC San Francisco in 1984.  In his first month of hospital clinical rotations as a pharmacy student, he set a career path toward hospital pharmacy and student precepting.  He completed two years of clinical residency training at University of Michigan Hospitals, Ann Arbor.  In 1986, he joined the clinical pharmacy faculty at The University of Texas College of Pharmacy precepting adult medicine rotations.  In 1990 he transitioned to part-time UT faculty status as he practiced hospital pharmacy in Austin, Round Rock, and Temple serving as a clinical pharmacy coordinator, hospital pharmacy director, and multi-hospital system pharmacy administrator.  He continued to precept hospital pharmacy, adult medicine, infectious disease, and pharmacy administration APPE rotations, as well as IPPE rotations with students through 2017 – for a total of thirty years of student precepting.  For eight years he served as hospital pharmacy residency program director.  Emory has held a visiting professor appointment with Toho University Faculty of Pharmaceutical Sciences, in Chiba, Japan for 12 years.  He served on the Board of Directors of the Texas Society of Health System Pharmacists for 10 years, including serving one term as President.

Disclosure:  Dr Martin has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.


This module may be counted as 1.00 hour of CE for Sterile Compounding certification maintenance

Objectives

  • List key components for compounding formula documents.
  • List some advantages and challenges of electronic systems for IV Workflow Management and documentation for required USP <797>-related tasks.

Activity Number

0067-0000-21-130-H07-P/T

Release Date: Jun 19, 2021
Credit Expiration Date: Jun 15, 2024

CE Hours

0.50
   

   

 
Sterile Compounding - Viable Environmental Surface Sampling
on-demand home study session
 

About the Faculty
 
Emory S. Martin, Pharm.D.
Pharmacy Project Specialist
Steward Health Care

Emory is a native of Houston, Texas and married Carolyn Reed of Rexburg, Idaho after he completed two years of voluntary missionary service in Japan.  They have five children and 16 grandchildren.  Emory graduated with a PharmD degree from UC San Francisco in 1984.  In his first month of hospital clinical rotations as a pharmacy student, he set a career path toward hospital pharmacy and student precepting.  He completed two years of clinical residency training at University of Michigan Hospitals, Ann Arbor.  In 1986, he joined the clinical pharmacy faculty at The University of Texas College of Pharmacy precepting adult medicine rotations.  In 1990 he transitioned to part-time UT faculty status as he practiced hospital pharmacy in Austin, Round Rock, and Temple serving as a clinical pharmacy coordinator, hospital pharmacy director, and multi-hospital system pharmacy administrator.  He continued to precept hospital pharmacy, adult medicine, infectious disease, and pharmacy administration APPE rotations, as well as IPPE rotations with students through 2017 – for a total of thirty years of student precepting.  For eight years he served as hospital pharmacy residency program director.  Emory has held a visiting professor appointment with Toho University Faculty of Pharmaceutical Sciences, in Chiba, Japan for 12 years.  He served on the Board of Directors of the Texas Society of Health System Pharmacists for 10 years, including serving one term as President.

Disclosure:  Dr Martin has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.


This module may be counted as 1.00 hour of CE for Sterile Compounding certification maintenance

Objectives

  • Contrast a basic vs. dynamic viable environmental sampling program

Activity Number

0067-0000-21-131-H07-P/T

Release Date: Jun 18, 2021
Credit Expiration Date: Jun 15, 2024

CE Hours

0.50
   

   

 
Sterile Compounding - Component Staging and Equipment Sanitizing
on-demand home study session
 

About the Faculty
 
Emory S. Martin, Pharm.D.
Pharmacy Project Specialist
Steward Health Care

Emory is a native of Houston, Texas and married Carolyn Reed of Rexburg, Idaho after he completed two years of voluntary missionary service in Japan.  They have five children and 16 grandchildren.  Emory graduated with a PharmD degree from UC San Francisco in 1984.  In his first month of hospital clinical rotations as a pharmacy student, he set a career path toward hospital pharmacy and student precepting.  He completed two years of clinical residency training at University of Michigan Hospitals, Ann Arbor.  In 1986, he joined the clinical pharmacy faculty at The University of Texas College of Pharmacy precepting adult medicine rotations.  In 1990 he transitioned to part-time UT faculty status as he practiced hospital pharmacy in Austin, Round Rock, and Temple serving as a clinical pharmacy coordinator, hospital pharmacy director, and multi-hospital system pharmacy administrator.  He continued to precept hospital pharmacy, adult medicine, infectious disease, and pharmacy administration APPE rotations, as well as IPPE rotations with students through 2017 – for a total of thirty years of student precepting.  For eight years he served as hospital pharmacy residency program director.  Emory has held a visiting professor appointment with Toho University Faculty of Pharmaceutical Sciences, in Chiba, Japan for 12 years.  He served on the Board of Directors of the Texas Society of Health System Pharmacists for 10 years, including serving one term as President.

Disclosure:  Dr Martin has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.


This module may be counted as 1.00 hour of CE for Sterile Compounding certification maintenance

Objectives

  • Identify best practices in staging ingredients and supplies.
  • Identify best practices in establishing effective sanitizing procedures.
  • Technician Objectives:
  • Explain component “staging” and when it should occur.
  • Identify fundamental concepts for effective cleaning and disinfection.

Activity Number

0067-0000-21-132-H07-P/T

Release Date: Jun 18, 2021
Credit Expiration Date: Jun 15, 2024

CE Hours

0.50
   

   

 
Sterile Compounding - Let's Talk About It: Required vs Best Practices in Sterile Compounding
on-demand home study session
 

About the Faculty 
 
Holli Temple, Pharm.D.
Clinical Associate Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
 

Dr. Holli Temple is a Clinical Assistant Professor in the Health Outcomes & Pharmacy Practice Division. She is a Course Coordinator for Introduction to Patient Care and the associated Care and Respect for the Elderly (CARE) Program. Additionally, she is the Inpatient Coordinator for Advanced Health Outcomes & Pharmacy Practice Experiences, Austin/Temple/Waco region.  Previously, Dr. Temple practiced pharmacy at North Austin Medical Center (NAMC) from 1995 – 2011.  Her responsibilities at NAMC focused on implementing and managing Clinical Pharmacy Services. In addition, she facilitated the Medication Safety Group and served as the NAMC representative to the Austin Multi-Institutional Review Board.   From 2000-2011, Dr. Temple precepted students on Adult Medicine and Institutional Pharmacy rotations and served the UT College of Pharmacy as the Institutional Coordinator for the Austin/Temple/Waco region. She has contributed to ASHP’s PharmPrep publication as an author and continues to be a section editor for the Renal Disorders chapter.  Academically, Holli completed her B.S. in Biomedical Science from Texas A&M University in 1992, her B.S. in Pharmacy from the University of Texas in 1994, and her Doctor of Pharmacy from the University of Texas in 1999.  Dr. Temple has received the following honors and awards associated with her pharmacy practice: recipient of the 2004 Caregiver of the Year award from North Austin Medical Center, named to the 2003 Rho Chi Alumni Honor Roll, and recipient of the 2002 Wm. Arlyn Kloesel Outstanding Preceptor Award.

Disclosure: Dr. Temple has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

 

Emory S. Martin, Pharm.D.
Pharmacy Project Specialist
Steward Health Care

Emory is a native of Houston, Texas and married Carolyn Reed of Rexburg, Idaho after he completed two years of voluntary missionary service in Japan.  They have five children and 16 grandchildren.  Emory graduated with a PharmD degree from UC San Francisco in 1984.  In his first month of hospital clinical rotations as a pharmacy student, he set a career path toward hospital pharmacy and student precepting.  He completed two years of clinical residency training at University of Michigan Hospitals, Ann Arbor.  In 1986, he joined the clinical pharmacy faculty at The University of Texas College of Pharmacy precepting adult medicine rotations.  In 1990 he transitioned to part-time UT faculty status as he practiced hospital pharmacy in Austin, Round Rock, and Temple serving as a clinical pharmacy coordinator, hospital pharmacy director, and multi-hospital system pharmacy administrator.  He continued to precept hospital pharmacy, adult medicine, infectious disease, and pharmacy administration APPE rotations, as well as IPPE rotations with students through 2017 – for a total of thirty years of student precepting.  For eight years he served as hospital pharmacy residency program director.  Emory has held a visiting professor appointment with Toho University Faculty of Pharmaceutical Sciences, in Chiba, Japan for 12 years.  He served on the Board of Directors of the Texas Society of Health System Pharmacists for 10 years, including serving one term as President.

Disclosure:  Dr Martin has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.


This module may be counted as 1.00 hour of CE for Sterile Compounding certification maintenance

Objectives

  • Compare and contrast master formulation records (MFR) and compounding records
  • Examine example master formulation record (compounding recipe)
  • Evaluate a MFR (compounding recipe) selected by participant
  • Debate "hot potato" topics including garbing order, removing overfill from IV bags, following which version of USP <797>, et al.

Activity Number

0067-0000-21-116-H07-P/T

Release Date: Jun 1, 2021
Credit Expiration Date: Jun 1, 2022

CE Hours

1.00
   

   

 
Pharmacist Analysis of Drug Diversion
on-demand home study session
 
Diane Ginsburg does not have any relevant financial relationships to disclose.

Objectives

  • Describe drugs involved in diversion and the impact on the opioid crisis
  • Discuss how to identify potential prescribing and diversion red flags and action steps regarding suspicious activities

Speaker(s)/Author(s)

Diane B. Ginsburg, Ph.D., M.S., R.Ph., FASHP  picture

Diane B. Ginsburg, Ph.D., M.S., R.Ph., FASHP
Associate Dean for Healthcare Partnerships / Chair and Clinical Professor of Pharmacy Practice, University of Texas at Austin College of Pharmacy

Activity Number

0067-0000-21-152-H03-P/T

Release Date: Sep 10, 2021
Credit Expiration Date: Sep 10, 2022

CE Hours

1.00
   

   

Please complete the overall evaluation to help us review this program and to help us in developing next year's agenda.
NOT eligible for CE credt.

 

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2022